Evidence map›Paper›PMID 29507028›Full record

ArticleBMJ case reports2018

Stroke thrombolysis complicated by ST elevation myocardial infarction (STEMI).

Mark Flower, James Harvey, Jonathan Hunter

Abstract readCase Reports
In one paragraph

Article in BMJ case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Mark FlowerDepartment of Medicine, Redcliffe Hospital, Redcliffe, Queensland, Australia.ORCID http://orcid.org/0000-0002-0983-2095
James HarveyDepartment of Medicine, Redcliffe Hospital, Redcliffe, Queensland, Australia.
Jonathan HunterDepartment of Medicine, Redcliffe Hospital, Redcliffe, Queensland, Australia.
Redcliffe Hospital · AUReef Ecologic · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An 84-year-old male Jehovah's Witness presented to the emergency department 1 hour after onset of left facial droop and left upper limb weakness. Thrombolytic stroke treatment was commenced as per local thrombolytic protocol with intravenous recombinant tissue plasminogen activator (rtPA) at 2 hours and 25 min following onset of symptoms. Almost immediately after rtPA infusion the patient reported chest pain and had ECG changes consistent with a diagnosis of anterior ST elevation myocardial infarction. At angiogram, a graft study showed severe native coronary artery disease. The left internal mammary artery graft was patent to the left anterior descending artery (LAD); however, the apical LAD was occluded, with the appearance suggestive of embolic occlusion.

Indexed as

Aged, 80 and overCoronary AngiographyCoronary Artery DiseaseCoronary VesselsElectrocardiographyFibrinolytic AgentsHumansMaleST Elevation Myocardial InfarctionStrokeTissue Plasminogen ActivatorTomography, X-Ray ComputedFibrinolytic AgentsTissue Plasminogen Activatorischaemic heart diseasesafetystrokeunwanted effects / adverse reactions

Identifiers

PMID29507028
PMCPMC5847940
OpenAlexW2792767849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.